ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)
$4.03 -0.02 (-0.4938%)
Analysed ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) News Sources
Lifeward Successfully Closes on Strategic Partnership with Oramed
25-03-2026
yahoo.com
Oramed: Q4 Earnings Snapshot
26-03-2026
yahoo.com
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors
14-04-2026
yahoo.com
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks
13-05-2026
yahoo.com
ORMP: Strategically Acquiring Interests in Medtech & Technology Companies
08-06-2026
yahoo.com
June 2026 Penny Stocks To Watch For Potential Growth
15-06-2026
yahoo.com
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
17-06-2026
yahoo.com
ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community
18-06-2026
yahoo.com
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
25-06-2026
yahoo.com
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
07-07-2026
yahoo.com
What is the current price of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)?
The current price of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) is $4.03.
ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) since the previous trading day is $-0.02.
ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) since the previous trading day is -0.4938%.
What is the most recent average sentiment score for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)?
The most recent average sentiment score for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)?
The most recent sentiment for ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ) is .
SEC-8K** Filing Available For ORAMED PHARMACEUTICALS INC (ORMP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.